- ►nih.gov [PDF] J Larsson, A Sellman, B Bauer - British Journal of Ophthalmology, 1997 - bjo.bmj.com AIM/BACKGROUND A new defect in the anticoagulant system has recently been
discovered—activated protein C resistance. The frequency of this disorder has
been shown to be increased in young patients (<50 years of age) with ... Cited by 18 - Related articles - BL Direct - All 7 versions
T Linna, A Ylikorkala, K Kontula, P Puska, T … - Thrombosis and haemostasis, 1997 - ncbi.nlm.nih.gov 1: Thromb Haemost. 1997 Jan;77(1):214-6. Prevalence of factor V Leiden in young
adults with retinal vein occlusion. Linna T, Ylikorkala ... Cited by 25 - Related articles - BL Direct - All 4 versions
JL Gottlieb, JP Blice, B Mestichelli, BA … - Archives of Ophthalmology, 1998 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 48 - Related articles - BL Direct - All 4 versions
PR Hodgkins, DJ Perry, SJ Sawcer, J Keast- … - Eye (London, England), 1995 - ncbi.nlm.nih.gov A number of anticoagulants are found in plasma, helping to maintain the balance
between thrombosis and haemorrhage. Two of the most important are antithrombin
and protein C, which inactivates factors V and VIII. Deficiencies are well- ... Cited by 20 - Related articles - BL Direct - All 2 versions
- ►bmj.com [PDF] TH Williamson, A Rumley, GD Lowe - British Medical Journal, 1996 - bjo.bmj.com Page 1. doi:10.1136/bjo.80.3.203 1996;80;203-208 Br. J. Ophthalmol. TH Williamson,
A Rumley and GD Lowe occlusion: a population controlled study. ... Cited by 73 - Related articles - BL Direct - All 7 versions
- ►bmj.com [PDF] J Larsson, E Olafsdottir, B Bauer - British Medical Journal, 1996 - bjo.bmj.com Abstract Background-Central retinal vein occlu- sion is a disease that is most
common in old people. While the disease in old people often is associated with
atherosclerosis, hypertension, diabetes, or glaucoma, this is much less ... Cited by 68 - Related articles - BL Direct - All 8 versions
FY Demirci, DB Güney, K Akarcay, N Kir, U … - Acta Ophthalmologica Scandinavica, 1999 - ncbi.nlm.nih.gov PURPOSE: Factor V Leiden mutation is a common genetic defect associated with a
tendency to venous thrombosis. The aim of this study was to evaluate the
prevalence of factor V Leiden in patients with retinal vein occlusion ... Cited by 9 - Related articles - All 4 versions
R Dhote, C Bachmeyer, MH Horellou, P Toulon … - American journal of ophthalmology, 1995 - ncbi.nlm.nih.gov PURPOSE/METHODS: Activated protein C resistance was recently described as a
major cause of venous thrombosis. We observed a central retinal vein thrombosis
in a woman with activated protein C resistance. RESULTS/CONCLUSION: DNA ... Cited by 23 - Related articles - BL Direct - All 2 versions
AP Ciardella, LA Yannuzzi, KB Freund, D … - Retina, 1998 - journals.lww.com FACTOR V LEIDEN • CIARDELLA ET AL 309 Fig. 1. Coagulation cascade. Protein С
circulates as an inactive zymo- gen, and is actived by enzymatic cleavage on the
surface of endothelial cells by a complex of thrombin and thrombomodulin. ... Cited by 24 - Related articles - BL Direct - All 3 versions
SLG FRACO, IG FRACO, BM AIMS, PB … - Clinical & Experimental Ophthalmology - interscience.wiley.com Purpose: Activated protein C (APC) resistance has recently been reported as
conferring a sevenfold increase in the risk of venous thrombosis. It is linked
to a genetic mutation in the factor V gene which occurs commonly (about 2% ... Cited by 12 - Related articles - BL Direct - All 2 versions
